共 48 条
Blockade of STAT3/IL-4 overcomes EGFR T790M-cis-L792F-induced resistance to osimertinib via suppressing M2 macrophages polarization
被引:13
|作者:
Sun, Yiting
[1
,2
]
Dong, Yiting
[1
,2
]
Liu, Xijuan
[3
]
Zhang, Yundi
[1
,2
]
Bai, Hua
[1
,2
]
Duan, Jianchun
[1
,2
]
Tian, Zhihua
[3
]
Yan, Xiang
[4
]
Wang, Jie
[1
,2
,5
]
Wang, Zhijie
[1
,2
,5
]
机构:
[1] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,State Key Lab Mol Oncol,Dep, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Peking Univ Canc Hosp & Inst, Dept Cent Lab, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol, Beijing, Peoples R China
[5] Chinese Acad Med Sci, Dept Med Oncol, State Key Lab Mol Oncol, Peking Union Med Coll,Natl Canc Ctr,Natl Clin Res, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R China
来源:
基金:
中国国家自然科学基金;
北京市自然科学基金;
关键词:
Non-small cell lung cancer;
EGFR;
L792F mutation;
Osimertinib resistance;
M2 macrophage polarization;
NONSMALL CELL LUNG;
BRAIN METASTASIS;
CANCER;
EGFR(T790M);
CODELIVERY;
DUPILUMAB;
AZD9291;
D O I:
10.1016/j.ebiom.2022.104200
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background The mechanism of missense alteration at EGFR L792F in patients with non-small cell lung cancer resistant to osimertinib has not been sufficiently clarified. We aimed to explore the critical molecular events and cop-ing strategies in osimertinib resistance due to acquired L792F mutation. Methods Circulating tumor DNA-based sequencing data of 1153 patients with osimertinib resistance were collected to illustrate the prevalence of EGFR L792F mutation. Sensitivity to osimertinib was tested with constructed EGFR 19Del/T790M-cis-L792F cell lines in vitro and in vivo. The correlation and linked pathways between M2 macrophage polarization and EGFR L792Fcis-induced osimertinib resistance were investigated. Possible interventions to suppress osimertinib resistance by targeting IL-4 or STAT3 were explored. Findings The concomitant EGFR L792F was identified as an independent mutation following the acquisition of T790M after osimertinib resistance, in that 5 of the 946 patients with osimertinib resistance harbored EGFR T790M-cis-L792F mutation. Transfected EGFR 19Del/T790M-cis-L792F in cell lines had decreased sensitivity to osimertinib and enhanced infiltrating macrophage with M2 polarization. Silico analyses confirmed the role of M2 polarization in osimertinib resistance induced by EGFR T790M-cis-L792F mutation. EGFR T790M-cis-L792F muta-tion upregulated phosphorylation of STAT3 Tyr705 and promoted its specific binding to IL4 promoter, enhancing IL-4 expression and secretion and inducing macrophage M2 polarization. Furthermore, blockade of STAT3/IL-4 (SH-4-54 or dupilumab) suppressed macrophage M2 polarization and regressed tumor sensitivity to osimertinib. Interpretation Our results proved that targeting EGFR T790M-cis-L792F/STAT3 Tyr705/IL-4 pathway could be a potential strategy to suppress osimertinib resistance in NSCLC. Copyright (c) 2022 The Authors. Published by Elsevier B.V. T
引用
收藏
页数:16
相关论文